|
|
||||||||
Eur J Cardiothorac Surg 1999;15:1-6
© 1999 Elsevier Science NL
a The Yorkshire Laser Centre, Goole and District Hospital, Woodland Avenue, Goole, East Yorkshire, UK
b Department of Applied Physics, The University of Hull, Hull, UK
c Centre for Photobiology and Photodynamic Therapy, The University of Leeds, Leeds, UK
Received 25 August 1998; received in revised form 19 October 1998; accepted 20 October 1998.
* Corresponding author. Tel./fax: +44-1724-290-456.
Objectives: The objectives of the study were: (1) to evaluate effectiveness of photodynamic therapy (PDT) for symptom palliation in patients with inoperable lung cancer; (2) to determine survival benefit in a subset of patients. Methods: One hundred patients, 68 male, 32 female, aged 4481 years (mean 62.5) with advanced inoperable bronchogenic cancer and endobronchial luminal obstruction were prospectively studied. Eighty-two percent had previous chemo/radiotherapy. The pre-treatment protocol consisted of: clinical, radiological and bronchoscopic examination, pulmonary function testing, assessment of WHO performance status and clinical staging. Treatment protocol was: intravenous injection of 2 mg/kg body weight of photofrin/polyhaematoporphyrin and interstitial illumination using 630 nm laser light 2472 h later. Follow-up was at 68 weeks for 1 year. Then every 36 months if applicable. Repeat PDT as necessary. Results: All patients were stage IIIaIV. The histology of the tumour was: non small cell in 90 and small cell in 10. There was no treatment related mortality. Mean endoluminal obstruction fell from 85.8% to 17.5%, mean forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) improvement was 430 ml and 280 ml, respectively. Ninety patients died from 6 weeks to 37 months, mean and median survival: 9 months and 5 months, respectively. Ten patients are alive from 13 to 72 months, mean 36 months, median 29 months. Overall 2-year survival was 19%. Multivariant analysis indicated that age, sex, histology and stage of disease did not influence survival significantly but performance status did. Patients with WHO<2 had mean and median survival of 17.8 and 14 months versus WHO>2, 6.9 mean and 4 months median survival (log-rank P<0.0001). Conclusions: (1) PDT is effective in palliation of inoperable advanced lung cancer. (2) Subset of patients with a better performance status have added survival benefit.
Key Words: Photodynamic therapy Lung cancer
This article has been cited by other articles:
![]() |
P. A. Kvale, P. A. Selecky, and U. B. S. Prakash Palliative Care in Lung Cancer: ACCP Evidence-Based Clinical Practice Guidelines (2nd Edition) Chest, September 1, 2007; 132(3_suppl): 368S - 403S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Moghissi, K. Dixon, J. A. C. Thorpe, M. Stringer, and C. Oxtoby Photodynamic therapy (PDT) in early central lung cancer: a treatment option for patients ineligible for surgical resection Thorax, May 1, 2007; 62(5): 391 - 395. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Wahidi, F. J. F. Herth, and A. Ernst State of the Art: Interventional Pulmonology Chest, January 1, 2007; 131(1): 261 - 274. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Triesscheijn, P. Baas, J. H. M. Schellens, and F. A. Stewart Photodynamic Therapy in Oncology Oncologist, October 1, 2006; 11(9): 1034 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Mortman and K. M. Frankel Pulmonary Resection After Successful Downstaging with Photodynamic Therapy Ann. Thorac. Surg., August 1, 2006; 82(2): 722 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
J-M. Vergnon, R. M. Huber, and K. Moghissi Place of cryotherapy, brachytherapy and photodynamic therapy in therapeutic bronchoscopy of lung cancers. Eur. Respir. J., July 1, 2006; 28(1): 200 - 218. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Asimakopoulos, J. Beeson, J. Evans, and M. O. Maiwand Cryosurgery for Malignant Endobronchial Tumors: Analysis of Outcome Chest, June 1, 2005; 127(6): 2007 - 2014. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ross Jr, C. M. Magro, and M. A. King Endobronchial histoplasmosis: a masquerade of primary endobronchial neoplasia--a clinical study of four cases Ann. Thorac. Surg., July 1, 2004; 78(1): 277 - 281. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ernst, D. Feller-Kopman, H. D. Becker, and A. C. Mehta Central Airway Obstruction Am. J. Respir. Crit. Care Med., June 15, 2004; 169(12): 1278 - 1297. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Maziak, B. R. Markman, J. A. MacKay, and W. K. Evans Photodynamic therapy in nonsmall cell lung cancer: a systematic review Ann. Thorac. Surg., April 1, 2004; 77(4): 1484 - 1491. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Moghissi and K. Dixon Is bronchoscopic photodynamic therapy a therapeutic option in lung cancer? Eur. Respir. J., September 1, 2003; 22(3): 535 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Moghissi, K. Dixon, and J.A. C. Thorpe A method for video-assisted thoracoscopic photodynamic therapy (VAT-PDT) Interactive CardioVascular and Thoracic Surgery, September 1, 2003; 2(3): 373 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kiani, C. M. Magro, P. Porcu, M. Starns, N. Heerema, and P. Ross Jr Polypoid endobronchial Hodgkin lymphoma with an initial response to photodynamic therapy Ann. Thorac. Surg., September 1, 2003; 76(3): 940 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Kiani, C. M. Magro, and P. Ross Jr Endobronchial presentation of Hodgkin lymphoma: a review of the literature Ann. Thorac. Surg., September 1, 2003; 76(3): 967 - 972. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Kvale, M. Simoff, and U. B. S. Prakash Palliative Care Chest, January 1, 2003; 123(1_suppl): 284S - 311S. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. A. Silvestri, C. Sherman, T. Williams, S.-S. Leong, P. Flume, and A. Turrisi Caring for the Dying Patient With Lung Cancer* Chest, September 1, 2002; 122(3): 1028 - 1036. [Full Text] [PDF] |
||||
![]() |
F. Tomaselli, A. Maier, H. Pinter, H. Stranzl, and F. M. Smolle-Juttner Photodynamic therapy enhanced by hyperbaric oxygen in acute endoluminal palliation of malignant bronchial stenosis (Clinical pilot study in 40 patients) Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 549 - 554. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Seijo and D. H. Sterman Interventional Pulmonology N. Engl. J. Med., March 8, 2001; 344(10): 740 - 749. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |